Induction of CD4+ murine natural killer T-like cells by immunization with syngeneic thymoma expressing embryonic α-fetoprotein

Cellular Immunology

Volumn 226, Issue 1, 2003, Pages 1-10

  Kim, Youngsoon ^a   Nakagawa, Yohko ^a   Sugiyama, Hirotaka ^a   Shimizu, Masumi ^a   Takeshita, Toshiyuki ^a   Araki, Tsutomu ^a   Takahashi, Hidemi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

CD4+; EL4; Embryonic antigen; IL 13; Immune response; NKT; Transfectant; Tumor; V 11; Fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; CD4 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CONTROL; CELL ACTIVITY; CELL LINE; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T LIKE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SCID MOUSE; THYMOMA; TUMOR CELL; TUMOR GROWTH;

MURINAE;

EID: 1642473150     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2003.10.006     Document Type: Article

References (30)

1. Marrink J., Sleijfer D.T., de Vries E.G., Schraffordt Koops H. Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage. Eur. J. Cancer. 26:1990;969-972.
2. Trevisani F., D'Intino P.E., Morselli-Labate A.M., Mazzella G., Accogli E., Caraceni P., Domenicali M., Notariis S.D., Roda E., Bernardi M. Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J. Hepatol. 34:2001;603-605.
3. Bendelac A., Rivera M., Park S., Roark J. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:1997;535-562.
4. Godfrey D., Hammond K.J.L., Poulton L., Smyth M., Baxter A. NKT cells: facts, functions and fallacies. Immunol. Today. 21:2000;573-583.
5. Yokoyama W.M., Seaman W.E. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11:1993;613-635.
6. Takahashi H. Antigen processing and presentation. Microbiol. Immunol. 37:1993;1-9.
7. + T cells mediate tumor rejection. J. Immunol. 168:2002;1-4.
8. - T cells in mice and humans. J. Exp. Med. 180:1994;1097-1106.
9. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., Kondo E., Harada M., Koseki H., Nakayama T., Tanaka Y., Taniguchi M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA. 95:1998;5690-5693.
10. + NK T cells in the early stages of embryogenesis. Proc. Natl. Acad. Sci. USA. 93:1996;6516-6520.
11. Takahashi H., Cohen J., Hosmalin A., Cease K.B., Houghten R., Cornette J.L., DeLisi C., Moss B., Germain R.N., Berzofsky J.A. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 85:1988;3105-3109.
12. Ceredig R., Lowenthal J.W., Nabholz M., MacDonald H.R. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature. 314:1985;98-100.
13. Sarmiento M., Glasebrook A.L., Fitch F.W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:1980;2665-2672.
14. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:1981;317-321.
15. Tilghman S.M. The structure and regulation of the α-fetoprotein and albumin genes. Oxford Surv. Eukaryot. Genes. 2:1985;160-206.
16. Sugiyama H., Papst P., Gelfand E.W., Terada N. p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229. J. Immunol. 157:1996;656-660.
17. Sugiyama H., Papst P., Fujita M., Gelfand E.W., Terada N. Overexpression of wild type p70 S6 kinase interferes with cytokinesis. Oncogene. 15:1997;443-452.
18. + HIV-1 envelope-specific murine CTLs by short exposure to antigenic peptide. J. Immunol. 169:2002;6588-6593.
19. Nakatsuka K., Sugiyama H., Nakagawa Y., Takahashi H. Purification of antigenic peptide from murine hepatoma cells recognized by class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells. J. Hepatol. 30:1999;1119-1129.
20. Ingram R.S., Scott R.W., Tilghman S.M. alpha-Fetoprotein and albumin genes are in tandem in the mouse genome. Proc. Natl. Acad. Sci. USA. 78:1981;4694-4698.
21. Sellem C.H., Frain M., Erdos T., Sala-Trepat J.M. Differential expression of albumin and α-fetoprotein genes in fetal tissues of mouse and rat. Dev. Biol. 102:1984;51-60.
22. Deutsch H.F. Chemistry and biology of α-fetoprotein. Adv. Cancer Res. 56:1991;253-312.
23. Nunez E.A. Biological role of α-fetoprotein in the endocrinological field: data and hypotheses. Tumor Biol. 15:1994;63-72.
24. Eberl G., Lees R., Smiley S.T., Taniguchi M., Grusby M.J., MacDonald H.R. Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells. J. Immunol. 162:1999;6410-6419.
25. Hammond K.J., Pelikan S.B., Crowe N.Y., Randle-Barrett E., Nakayama T., Taniguchi M., Smyth M.J., van Driel I.R., Scollay R., Baxter A.G. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29:1999;3768-3781.
26. + cells: new clues to their origin, specificity, and function. J. Exp. Med. 182:1995;633-638.
27. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629.
28. Schofield L., McConville M.J., Hansen D., Campbell A.S., Fraser-Reid B., Grusby M.J., Tachado S.D. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science. 283:1999;225-229.
29. Baker J., Verneris M.R., Ito M., Shizuru J.A., Negrin R.S. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood. 97:2001;2923-2931.
30. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., Carbone D.P., Paul W.E., Berzofsky J.A. NKT cell-mediated repression of tumor immunosurveillance by IL13 and the IL-4R-STAT6 pathway. Nat. Immunol. 6:2000;515-520.